Risk factors and outcomes of Pneumocystis jiroveciii pneumonia in Christchurch, New Zealand: a retrospective clinical study
Open Access
- 25 September 2026
- journal article
- research article
- Published by Taylor & Francis in Infectious Diseases
- p. 1-10
Abstract
Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal infection first described in the early 1900s that predominantly affects severely immunocompromised individuals. Historically, popul...Keywords
This publication has 15 references indexed in Scilit:
- Prophylaxis Against Pneumocystis PneumoniaJAMA, 2023
- Prophylaxis Against Pneumocystis jirovecii Pneumonia in AdultsJAMA, 2023
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)Leukemia, 2019
- Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patientsInternational Journal of Infectious Diseases, 2016
- Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014Internal Medicine Journal, 2014
- Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsCochrane Database of Systematic Reviews, 2014
- Pneumocystis Pneumonia in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspectiveBone Marrow Transplantation, 2009
- Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1977